DRI Healthcare Reports Third Quarter 2026 Results
DRI Healthcare to Host Third Quarter 2026 Earnings Call and Webcast on November 5, 2026
DRI Healthcare Comments on Juvmo's (tavapadon) FDA Approval
Tavapadon Conference Call
DRI Healthcare Announces US$316 Million Purchase of Tavapadon Royalty
DRI Healthcare Announces Receipt of Put Price on EKTERLY
Second Quarter 2026 Earnings Call